Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

494 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy.
Loeb S, Roehl KA, Viprakasit DP, Catalona WJ. Loeb S, et al. Among authors: catalona wj. Eur Urol. 2008 Jul;54(1):88-94. doi: 10.1016/j.eururo.2008.03.066. Epub 2008 Apr 1. Eur Urol. 2008. PMID: 18400368
T rosette assay: in vitro correlate of cellular immunity.
Catalona WJ, Potvin C, Tarpley JL, Chretien PB. Catalona WJ, et al. Urology. 1974 Jul;4(1):100-4. doi: 10.1016/0090-4295(74)90119-8. Urology. 1974. PMID: 21322996
Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer.
Naughton M, Picus J, Zhu X, Catalona WJ, Vollmer RT, Humphrey PA. Naughton M, et al. Among authors: catalona wj. J Urol. 2001 Apr;165(4):1325-8. J Urol. 2001. PMID: 11257710
Lowering PSA cutoffs to enhance detection of curable prostate cancer.
Catalona WJ, Ramos CG, Carvalhal GF, Yan Y. Catalona WJ, et al. Urology. 2000 Jun;55(6):791-5. doi: 10.1016/s0090-4295(99)00602-0. Urology. 2000. PMID: 10840078 No abstract available.
Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies.
Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Keetch DW, et al. Among authors: catalona wj. J Urol. 1996 Aug;156(2 Pt 1):428-31. doi: 10.1097/00005392-199608000-00025. J Urol. 1996. PMID: 8683695 Clinical Trial.
Screening for prostate cancer: enthusiasm.
Catalona WJ. Catalona WJ. Urology. 1993 Aug;42(2):113-5. doi: 10.1016/0090-4295(93)90632-k. Urology. 1993. PMID: 7690167 No abstract available.
Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml.
Colberg JW, Smith DS, Catalona WJ. Colberg JW, et al. Among authors: catalona wj. J Urol. 1993 Mar;149(3):507-9. doi: 10.1016/s0022-5347(17)36130-x. J Urol. 1993. PMID: 7679753
Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study.
Snow PB, Smith DS, Catalona WJ. Snow PB, et al. Among authors: catalona wj. J Urol. 1994 Nov;152(5 Pt 2):1923-6. doi: 10.1016/s0022-5347(17)32416-3. J Urol. 1994. PMID: 7523737
Radical surgery for advanced prostate cancer and for radiation failures.
Catalona WJ. Catalona WJ. J Urol. 1992 Mar;147(3 Pt 2):916. doi: 10.1016/s0022-5347(17)37421-9. J Urol. 1992. PMID: 1538496 No abstract available.
Transrectal ultrasonography in the diagnosis and staging of carcinoma of the prostate.
Andriole GL, Kavoussi LR, Torrence RJ, Lepor H, Catalona WJ. Andriole GL, et al. Among authors: catalona wj. J Urol. 1988 Oct;140(4):758-60. doi: 10.1016/s0022-5347(17)41805-2. J Urol. 1988. PMID: 3047436
494 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback